Traditional gene therapies delivered via AAVs are not pursued because the gene therapy cannot be turned off if adverse effects occur. — Whalespan
Traditional gene therapies delivered via AAVs are not pursued because the gene therapy cannot be turned off if adverse effects occur.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“the primary delivery vectors of most the gene therapies out today are via aavs and once you get an aav in you can't turn off the gene therapy so if something goes wrong and has cancer progression you can't turn it off and we didn't want to take that Gamble”